Patient no. | Age/gender | Affected eye | History of ocular disease | Duration before CMV detection (months) | History of antiviral medication | History of topical antiviral medication |
1 | 76/M | Left | – | 57 | Valganciclovir oral | 0.15% Ganciclovir gel |
2 | 38/M | Left | – | 12 | – | – |
3 | 28/M | Left | – | 18 | – | – |
4 | 59/M | Left | Corneal decompensate | 57 | IV ganciclovir | 0.15% Ganciclovir gel |
5 | 50/F | Right | – | 204 | – | – |
6 | 53/M | Left | Primary open angle glaucoma | 62 | – | – |
7 | 52/M | Right | – | 62 | – | – |
8 | 41/M | Left | Behcet’s disease on cyclophosphamide | 1 | IVT ganciclovir | – |
9 | 33/F | Left | – | 48 | – | – |
10 | 81/M | Left | S/P PKP | 60 | – | – |
11 | 29/F | Right | S/P PKP | 14 | – | – |
M, male; F, female; IV, intravenous; IVT, intravitreous; S/P PKP, post penetrating keratopathy.